Objectives: To assess the prevalence of traditional vaginal agent use
in Malawian women and its association with HIV infection. Methods: Con
senting, consecutive antenatal women were administered a questionnaire
and screened for sexually transmitted diseases (STD) including HIV. R
esults: Of the 6603 consenting women, 886 (13%) reported using intrava
ginal agents for tightening and 2222 (34%) for self-treatment of vagin
al discharge and itching. A higher proportion of HIV-infected than uni
nfected women (17% versus 14%) reported use of intravaginal agents for
treatment (odds ratio, 1.29; 95% confidence interval, 1.05-1.57),but
no difference in HIV status was found when these agents were used for
tightening. In multivariate analysis, vaginal agent use for treatment
was independently associated with HIV seropositivity. Conclusions: The
association of HIV infection with vaginal agents for self-treatment,
but not for tightening, suggests that STD may play a role or that vagi
nal agents are used differently for the two purposes. In addition to a
small increased risk of HIV infection associated with vaginal agent u
se, these agents may interfere with condom effectiveness or acceptabil
ity of vaginal microbicides.